BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 32479996)

  • 1. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
    Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
    Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
    Spangenberg E; Severson PL; Hohsfield LA; Crapser J; Zhang J; Burton EA; Zhang Y; Spevak W; Lin J; Phan NY; Habets G; Rymar A; Tsang G; Walters J; Nespi M; Singh P; Broome S; Ibrahim P; Zhang C; Bollag G; West BL; Green KN
    Nat Commun; 2019 Aug; 10(1):3758. PubMed ID: 31434879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
    Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
    J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
    Clayton K; Delpech JC; Herron S; Iwahara N; Ericsson M; Saito T; Saido TC; Ikezu S; Ikezu T
    Mol Neurodegener; 2021 Mar; 16(1):18. PubMed ID: 33752701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
    Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
    Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
    Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
    Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
    Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
    Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model.
    Henningfield CM; Soni N; Lee RW; Sharma R; Cleland JL; Green KN
    Alzheimers Res Ther; 2024 May; 16(1):101. PubMed ID: 38711159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
    Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
    Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain.
    Crapser JD; Spangenberg EE; Barahona RA; Arreola MA; Hohsfield LA; Green KN
    EBioMedicine; 2020 Aug; 58():102919. PubMed ID: 32745992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
    Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.
    Zhao R; Hu W; Tsai J; Li W; Gan WB
    Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
    von Saucken VE; Jay TR; Landreth GE
    Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.